Israel’s ImmPACT Bio is developing transformative logic-gate-based CAR-T cell therapies for cancer patients who have exhausted their treatment options. The technology is designed to distinguish cancerous cells from normal cells, thereby eliminating tumors without damaging normal tissues.
https://en.globes.co.il/en/article-cancer-therapy-co-immpact-bio-raises-111m-1001399387